Pages that link to "Q34004213"

The following pages link to Characterization and formulation of multiple epitope-specific neutralizing monoclonal antibodies for passive immunization against cryptosporidiosis (Q34004213):

Displaying 23 items.

• Cryptosporidium pathogenicity and virulence (Q26823336) (← links)
• Prospects for immunotherapy and vaccines against Cryptosporidium (Q27005885) (← links)
• Display and selection of chicken IgA Fab fragments. (Q33226931) (← links)
• Antibodies fused to innate immune molecules reduce initiation of Cryptosporidium parvum infection in mice (Q33768898) (← links)
• Biochemical and functional characterization of CpMuc4, a Cryptosporidium surface antigen that binds to host epithelial cells (Q33815751) (← links)
• Characterization of an intestinal epithelial cell receptor recognized by the Cryptosporidium parvum sporozoite ligand CSL (Q34006422) (← links)
• Efficacy of monoclonal antibodies against defined antigens for passive immunotherapy of chronic gastrointestinal cryptosporidiosis (Q34105139) (← links)
• Cryptosporidium virulence determinants--are we there yet? (Q34863001) (← links)
• Recent advances in cryptosporidiosis: the immune response (Q34793048) (← links)
• Biology, persistence and detection of Cryptosporidium parvum and Cryptosporidium hominis oocyst (Q35652353) (← links)
• Systemic antibody responses to the immunodominant p23 antigen and p23 polymorphisms in children with cryptosporidiosis in Bangladesh (Q35716428) (← links)
• Primary immunodeficiencies and susceptibility to parasitic infections. (Q36624178) (← links)
• Elongation factor-1α is a novel protein associated with host cell invasion and a potential protective antigen of Cryptosporidium parvum (Q37333830) (← links)
• Cryptosporidiosis: host immune responses and the prospects for effective immunotherapies (Q37949643) (← links)
• Cryptosporidium infections: molecular advances (Q38200248) (← links)
• Extended-spectrum antiprotozoal bumped kinase inhibitors: A review (Q39075089) (← links)
• Vaccination with Eimeria tenella elongation factor-1α recombinant protein induces protective immunity against E. tenella and E. maxima infections (Q40093955) (← links)
• Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis. (Q40421224) (← links)
• Present and future control of cryptosporidiosis in humans and animals. (Q40460370) (← links)
• Antibody fusions reduce onset of experimental Cryptosporidium parvum infection in calves (Q42153077) (← links)
• Phospholipases and Cationic Peptides Inhibit Cryptosporidium parvum Sporozoite Infectivity by Parasiticidal and Non-Parasiticidal Mechanisms (Q45226978) (← links)
• Calf Clinical Model of Cryptosporidiosis for Efficacy Evaluation of Therapeutics (Q92886172) (← links)
• A symbiotic bacterium of shipworms produces a compound with broad spectrum anti-apicomplexan activity (Q95845964) (← links)